| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,282 |
25,217 |
$2.40M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,265 |
11,400 |
$1.52M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,164 |
6,987 |
$773K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,686 |
6,401 |
$673K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,503 |
4,391 |
$485K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,329 |
2,259 |
$271K |
| 90686 |
|
5,664 |
5,419 |
$127K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,664 |
11,370 |
$122K |
| 90648 |
|
5,145 |
4,960 |
$115K |
| 99381 |
|
945 |
891 |
$103K |
| 90671 |
|
1,761 |
1,686 |
$91K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,144 |
6,509 |
$86K |
| 90723 |
|
3,663 |
3,529 |
$82K |
| 92551 |
|
8,099 |
7,868 |
$76K |
| 90670 |
|
3,289 |
3,217 |
$75K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,316 |
1,212 |
$56K |
| 87428 |
|
1,854 |
1,714 |
$54K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,132 |
1,952 |
$51K |
| 90633 |
|
2,083 |
2,008 |
$47K |
| 90681 |
|
2,052 |
1,988 |
$46K |
| D1206 |
Topical application of fluoride varnish |
2,476 |
2,126 |
$44K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,668 |
1,292 |
$28K |
| 90716 |
|
990 |
958 |
$23K |
| 90651 |
|
965 |
933 |
$23K |
| 90734 |
|
926 |
899 |
$21K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,291 |
1,224 |
$21K |
| 90700 |
|
912 |
884 |
$21K |
| 90707 |
|
900 |
881 |
$20K |
| 83655 |
|
1,789 |
1,711 |
$20K |
| 90710 |
|
816 |
782 |
$19K |
| 90656 |
|
795 |
782 |
$18K |
| 99173 |
|
7,160 |
6,978 |
$18K |
| 90696 |
|
773 |
740 |
$17K |
| 94760 |
|
9,728 |
8,750 |
$16K |
| 99050 |
|
765 |
687 |
$10K |
| 90715 |
|
430 |
416 |
$10K |
| 96127 |
|
1,593 |
1,498 |
$8K |
| 90381 |
|
66 |
66 |
$6K |
| 87807 |
|
497 |
458 |
$5K |
| 99383 |
|
44 |
40 |
$5K |
| 99460 |
|
52 |
48 |
$5K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
27 |
26 |
$5K |
| 85018 |
|
1,918 |
1,835 |
$4K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
54 |
50 |
$4K |
| 90620 |
|
101 |
91 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
237 |
199 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
110 |
101 |
$2K |
| 99384 |
|
12 |
12 |
$2K |
| 90380 |
|
29 |
29 |
$2K |
| 0071A |
|
42 |
40 |
$2K |
| 0072A |
|
35 |
34 |
$1K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
76 |
76 |
$700.00 |
| 99051 |
|
55 |
54 |
$669.46 |
| 81003 |
|
285 |
263 |
$568.98 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
223 |
202 |
$407.13 |
| 99000 |
|
4,745 |
4,114 |
$333.01 |
| 90660 |
|
12 |
12 |
$279.36 |
| 94664 |
|
13 |
13 |
$182.00 |
| 94761 |
|
82 |
70 |
$150.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
134 |
126 |
$140.51 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
224 |
192 |
$90.04 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
67 |
59 |
$50.32 |
| 36416 |
|
141 |
132 |
$30.00 |
| 36415 |
Collection of venous blood by venipuncture |
12 |
12 |
$18.00 |
| 91308 |
|
17 |
16 |
$0.00 |
| 91307 |
|
82 |
79 |
$0.00 |
| INVCD |
|
12 |
12 |
$0.00 |